Evidence-Based Gastroenterology
Latest Publications

TOTAL DOCUMENTS

420

(FIVE YEARS 0)

H-INDEX

2

(FIVE YEARS 0)

Published By Ovid Technologies (Wolters Kluwer) - Lippincott Williams & Wilkins

1527-8557

Latest Documents Most Cited Documents Contributed Authors Related Sources Related Keywords

PHARMACOLOGIC PROPHYLAXIS OF POST-ERCP PANCREATITIS: IS ALLOPURINOL THE ANSWER?

Evidence-Based Gastroenterology ◽

10.1097/ebg.0b013e31818d69b1 ◽

2008 ◽

Vol 9 (4) ◽

pp. 73-74

Author(s):

Stuart Sherman

Keyword(s):

Pharmacologic Prophylaxis

Download Full-text

RECOMBINANT FACTOR VIIA—IS IT SAFE OR EFFECTIVE FOR VARICEAL BLEEDING IN CIRRHOSIS?

Evidence-Based Gastroenterology ◽

10.1097/ebg.0b013e31818d66e0 ◽

2008 ◽

Vol 9 (4) ◽

pp. 60-61

Author(s):

Neeral Shah ◽

Stephen Caldwell

Keyword(s):

Variceal Bleeding ◽

Recombinant Factor Viia ◽

Download Full-text

SHOULD WE USE ENDOSCOPIC OR BETA-BLOCKER THERAPY FOR PREVENTION OF FIRST VARICEAL HEMORRHAGE?

Evidence-Based Gastroenterology ◽

10.1097/ebg.0b013e31818d40ef ◽

2008 ◽

Vol 9 (4) ◽

pp. 62-63

Author(s):

Atif Zaman

Keyword(s):

Beta Blocker ◽

Variceal Hemorrhage ◽

Blocker Therapy ◽

Beta Blocker Therapy

Download Full-text

IS CT A VIABLE SCREENING MODALITY FOR ESOPHAGEAL VARICES?

Evidence-Based Gastroenterology ◽

10.1097/ebg.0b013e31818d699a ◽

2008 ◽

Vol 9 (4) ◽

pp. 64-65

Author(s):

Brent Lee ◽

Jonathan M. Schwartz

Keyword(s):

Esophageal Varices

Download Full-text

IMMUNOMODULATORS CAN BE DISCONTINUED IN PATIENTS ON SCHEDULED INFLIXAMAB TREATMENT

Evidence-Based Gastroenterology ◽

10.1097/ebg.0b013e31818d66f2 ◽

2008 ◽

Vol 9 (4) ◽

pp. 75-77

Author(s):

Darby E. Robinson OʼNeill ◽

Scott D. Lee

Download Full-text

CAN VIDEO CAPSULE ENDOSCOPY REPLACE STANDARD ENDOSCOPY TO SCREEN FOR ESOPHAGEAL VARICES?

Evidence-Based Gastroenterology ◽

10.1097/ebg.0b013e31818d66cf ◽

2008 ◽

Vol 9 (4) ◽

pp. 66-68

Author(s):

Asma Anwar ◽

Jason A. Dominitz

Keyword(s):

Capsule Endoscopy ◽

Esophageal Varices ◽

Video Capsule Endoscopy

Download Full-text

CAN WE USE CLINICAL PARAMETERS TO PREDICT NONALCOHOLIC STEATOHEPATITIS IN MORBIDLY OBESE PATIENTS?

Evidence-Based Gastroenterology ◽

10.1097/ebg.0b013e31818d4110 ◽

2008 ◽

Vol 9 (4) ◽

pp. 69-70

Author(s):

Nila Rafiq ◽

Zobair M. Younossi

Keyword(s):

Nonalcoholic Steatohepatitis ◽

Morbidly Obese ◽

Clinical Parameters ◽

Download Full-text

CAN THE DOSE OF RIBAVIRIN BE REDUCED FOR PATIENTS INFECTED WITH HEPATITIS C, GENOTYPES 2 AND 3?

Evidence-Based Gastroenterology ◽

10.1097/ebg.0b013e31818d4120 ◽

2008 ◽

Vol 9 (4) ◽

pp. 71-72

Author(s):

Ine-Mari Bornman ◽

Zobair M. Younossi

Keyword(s):

Download Full-text

Letter From the Editor

Evidence-Based Gastroenterology ◽

10.1097/ebg.0b013e31818e1d57 ◽

2008 ◽

Vol 9 (4) ◽

pp. 59

Author(s):

Glenn Eisen

Download Full-text

TUMOR NECROSIS FACTOR ANTAGONISTS FOR CROHNʼS DISEASE: EFFECTIVE, BUT SAFE?

Evidence-Based Gastroenterology ◽

10.1097/ebg.0b013e31818d40ff ◽

2008 ◽

Vol 9 (4) ◽

pp. 78-79

Author(s):

Jason M. Swoger ◽

Sunanda V. Kane

Keyword(s):

Tumor Necrosis Factor ◽

Tumor Necrosis ◽

Tumor Necrosis Factor Antagonists ◽

Necrosis Factor

Download Full-text